Australia's medical body advises conditional use of puberty blockers
Summarised from 2 outlets · Updated 16 Nov, 04:01 · Archive
Australia's National Health and Medical Research Council has recommended conditional use of puberty blockers for transgender children.
Australia's National Health and Medical Research Council, the country's largest medical research organisation, has released interim national clinical practice guidelines recommending puberty blockers can be used for gender-affirming care of young people in certain circumstances. The guidance follows a year-long review of international evidence commissioned by the federal government in response to bans in Queensland and Northern Territory public hospitals.
Under the NHMRC's recommendation, puberty blockers may be considered for people under 18 who have started puberty and experience 'gender incongruence' – a mismatch between the sex a person was born into and the gender they feel they are. Treatment requires assessment for suitability and joint decision-making involving the young person, their parents or carers, and clinicians. Federal Health Minister Mark Butler said any treatment would require thorough health assessment, multidisciplinary input, and ongoing monitoring of patients.
The NHMRC explicitly rejected alternative approaches such as 'wait and see' models, stating these withhold care for children and 'can affect the young person's physical and mental health, wellbeing, and ability to function'. Puberty blockers are a class of drugs used to stop the body producing oestrogen and testosterone, already used for decades to treat other conditions and covered by the Pharmaceutical Benefits Scheme for cisgender patients.
The interim guidelines stand in contrast to moves in the UK and a growing number of US states to restrict access to the drugs. The guidelines are open for public consultation.

How it is being reported
- Puberty blockers get interim green light for under 18s in Australia despite bans overseasPuberty blockers for minors have been given the green light in Australia, despite bans overseas.Daily Mail · 16 Nov, 03:36
- Australia’s national medical research body advises conditional use of puberty blockers for transgender childrenNew National Health and Medical Research Council guidelines at odds with public hospital bans in Queensland and NT Get our breaking news email , free app or daily news podcast Australia’s largest medical research organisation has advised puberty blockers are appropriate for the gender-affirming care of young people in certain circumstances, following a year-long review of international evidence. The federal government last year commissioned the commonwealth-funded National Health and Medical Research Council (NHMRC) to develop the advice in response to bans in Queensland and the Northern…Guardian World · 16 Nov, 03:15
In this story: National Health and Medical Research Council · Queensland · Northern Territory · Mark Butler · Australia
This summary was written by AI from the headlines and standfirsts above, and states as fact only what at least two outlets report. How we use AI · Report a problem · Corrections log
Comments (0)